Corcept Therapeutics, Inc. (NASDAQ: CORT)


Date: 
Tue, 03/22/2011

March 22nd, 2011 we released our public article, "TooNiceStocks Initiates Coverage on Corcept Therapeutics Inc. (NASDAQ: CORT) Evaluating the Benefits of Corlux".  Future implications show that CORT will request priority review with the U.S. Food and Drug Administration.  TooNiceStocks members were notified @ $3.93 and rallied up to $5.07, thats a 29% increase.  Read full report here.

 

 



Join our Free Newsletter!